Predicted to enable DNA-binding transcription repressor activity, RNA polymerase II-specific and RNA polymerase II transcription regulatory region sequence-specific DNA binding activity. Predicted to be involved in negative regulation of transcription by RNA polymerase II. Is expressed in several structures, including brain; genitourinary system; heart; hemolymphoid system gland; and liver. [provided by Alliance of Genome Resources, Apr 2022]